DeepMed Research

THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.qduh.cn

Clinical Trials

Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial

Not Applicable

Recruiting

Conditions: Gastric Cancer

Interventions: Drug: Chimeric antigen receptor T cell preparation targeting Claudin18.2

First Posted Date: 2023-07-19

Last Posted Date: 2023-07-19

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 9

Registration Number: NCT05952375

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

Not Applicable

Recruiting

Conditions: Gastric Cancer
Neoadjuvant Chemotherapy

Interventions: Drug: live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules

First Posted Date: 2023-06-13

Last Posted Date: 2023-06-13

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 318

Registration Number: NCT05901779

Locations: 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China

XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation

Not Applicable

Recruiting

Conditions: Colon Cancer

Interventions: Drug: Chimeric antigen receptor T cell preparation targeting GCC

First Posted Date: 2023-05-25

Last Posted Date: 2023-05-25

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 9

Registration Number: NCT05875402

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

Phase 3

Recruiting

Conditions: Gastric Cancer

Interventions: Procedure: Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

First Posted Date: 2023-05-23

Last Posted Date: 2023-05-23

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 616

Registration Number: NCT05871099

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: test apixaban tablets
Drug: reference apixaban tablets

First Posted Date: 2023-05-03

Last Posted Date: 2023-05-03

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 54

Registration Number: NCT05841446

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China

Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects

Phase 1

Completed

Conditions: Therapeutic Equivalency

Interventions: Drug: Reference Irbesartan Tablet
Drug: Tested Irbesartan Tablet

First Posted Date: 2023-03-27

Last Posted Date: 2023-03-27

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 68

Registration Number: NCT05786339

Locations: 🇨🇳
Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China

The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery

Not Applicable

Recruiting

Conditions: Renal Cyst
Renal Cell Carcinoma
Ureteral Tumor
Bladder Cancer
Prostate Cancer
Renal Calculi
Penile Cancer
Ureteropelvic Junction Obstruction
Adrenal Tumor
Renal Pelvis Carcinoma

Interventions: Device: telesurgery by domestic surgical robot

First Posted Date: 2023-02-22

Last Posted Date: 2023-07-14

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 100

Registration Number: NCT05739812

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects

Phase 1

Completed

Conditions: Hyperlipidemias

Interventions: Drug: ezetimibe tablet(Ezetrol ®)
Drug: ezetimibe tablet

First Posted Date: 2023-01-12

Last Posted Date: 2023-01-12

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 59

Registration Number: NCT05681247

Locations: 🇨🇳
Clinical Research Center, Qingdao, Shandong, China

Coca-cola's Clinical Effects on Gastric Phytobezoars

Not Applicable

Completed

Conditions: Bezoars

Interventions: Other: dieting Coca-cola

First Posted Date: 2022-12-09

Last Posted Date: 2022-12-09

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 492

Registration Number: NCT05645263

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Synovitis in Patients With Osteoarthritis

Completed

Conditions: Osteoarthritis, Knee

Interventions: Procedure: Total knee arthroplasty due to advanced osteoarthritis.

First Posted Date: 2022-11-15

Last Posted Date: 2023-01-04

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 272

Registration Number: NCT05617573

Locations: 🇨🇳
The affiliated hospital of Qingdao University, Qingdao, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy